Metropolitan Life Insurance Company (MetLife)’s HI-TECH PHARMACAL INC HITK Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-10,198	Closed	-$442K	–	2863
2014 Q1	$442K	Hold	10,198	–	–	﹤0.01%	1900
2013 Q4	$442K	Hold	10,198	–	–	﹤0.01%	1891
2013 Q3	$440K	Hold	10,198	–	–	﹤0.01%	1834
2013 Q2	$339K	Buy	+10,198	New	+$339K	﹤0.01%	1960

Metropolitan Life Insurance Company (MetLife)'s HITK Position: Q2 2014 in Review

Metropolitan Life Insurance Company (MetLife) sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 10,198 shares — an estimated $442K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $442K in Q1 2014. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Metropolitan Life Insurance Company (MetLife) reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 10,198 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $442K.
Metropolitan Life Insurance Company (MetLife) first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Metropolitan Life Insurance Company (MetLife)'s HI-TECH PHARMACAL INC position peaked at $442K in Q1 2014.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2014, filed 31 Jul 2014.